Skip to content

Sevoflurane, Propofol, Postoperative Pain

Postoperative Pain After Propofol Sevoflurane Anaesthesia: a Prospective, Randomized, Single-blinded Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01437462
Enrollment
168
Registered
2011-09-21
Start date
2008-10-31
Completion date
2013-03-31
Last updated
2013-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological Disease, Healthy Adults

Keywords

Pain, Postoperative, Anesthetics, intravenous, Anesthetics, inhalation, Otherwise healthy adults undergoing general anesthesia for gynecological disease.

Brief summary

The impact of anaesthetic method (intravenous vs. inhalational) has been proposed, but not proven in a large-scale study. The researchers aim to provide an investigation that has sufficient power to clarify the potential effect of anaesthetic method on postoperative need of opioids. Sevoflurane and propofol will be compared.

Interventions

DRUGSevoflurane

Sevoflurane inhalation anesthesia, sufficient amount to maintain adequate general anesthesia for surgery

DRUGPropofol

Propofol intravenous anesthesia, sufficient amount to maintain adequate anesthesia during surgery

Sponsors

Tampere University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-69 years * Gender: female * ASA status 1-3 * Laparoscopic hysterectomy

Exclusion criteria

* Body Mass Index over 35 * Diabetes mellitus * Liver disease * Allergies to pharmaceuticals used in the Study * Present use of opioids

Design outcomes

Primary

MeasureTime frameDescription
Postoperative consumption of an opioid (oxycodone)20 hoursThe consumption of oxycodone will be monitored by recording the amount of the drug received via a commercially available patient controlled analgesia (PCA) pump.

Secondary

MeasureTime frameDescription
NRS (numeral rating scale) of pain20 hoursNRS is evaluated frequently during the study period.

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026